Results 31 to 40 of about 9,409 (259)

A Rare Case of Collecting Duct Carcinoma With Extensive Coagulative Necrosis. [PDF]

Cureus, 2023
Collecting duct carcinoma (CDC) is an aggressive renal malignancy with limited diagnostic and therapeutic consensus. We report a case of a 69-year-old male with CDC and extensive coagulative necrosis who presented with lower extremity swelling, abdominal
Colef R, Mescallado L, Kiran N, Wrzolek M, Khan S.   +4 more
europepmc   +3 more sources

Bellini Duct Carcinoma: A Rare Entity [PDF]

Journal of Clinical and Diagnostic Research, 2016
Bellini duct carcinoma of kidney derives from collecting duct and is associated with an aggressive course and extremely poor prognosis. Here, we report an interesting case of Collecting Duct Carcinoma (CDC) with Inferior Vena Cava (IVC) thrombus and ...
Amit Kumar Mishra, Ramanitharan Manikandan, Lalgudi Narayan Dorairajan, Jayesh Kumar Mittal, Jinkala Sree Rekha   +4 more
doaj   +1 more source

Collecting duct carcinoma of the kidney: diagnosis and implications for management

, 2021
•Collecting duct carcinoma is a rare medullary based high-grade carcinoma•Overlapping features with other medullary based carcinomas make diagnosis challenging•Collecting duct carcinoma lacks recurrent molecular abnormalities•Collecting duct carcinoma is
Arias-Stella, Javier A, Kryvenko, Oleksandr N, Pal, Sumanta K, Cabanillas, Gerardo, Montoya-Cerrillo, Diego   +4 more
core   +1 more source

Collecting duct carcinoma of the kidney – A clinicopathological overview

Journal of Medical Evidence, 2022
Pakesh Baishya, Ravi Hari Phulware, Sanjeev Kishore, Ankur Mittal, Pankaj Sharma   +4 more
doaj   +2 more sources

Collecting Duct Carcinoma of the Kidney

British Journal of Urology, 1993
Summary— Collecting duct carcinoma (CDC) is a recently recognised histological variety of renal carcinoma (RC) considered to arise from the epithelium of the collecting ducts. Diagnosis of this entity depends on well defined gross and microscopic criteria and is supported by a characteristic immunostaining ...
Dimopoulos, MA, Logothetis, CJ, Markowitz, A, Sella, A, Amato, R, Ro, Jae   +5 more
openaire   +4 more sources

Additional file 6 of A genomic mutation spectrum of collecting duct carcinoma in the Chinese population

, 2022
Additional file 6: Figure S3.
Jing Li (10611), Huaru Zhang (10504787), Liqun Huang (409179), Qing Yang (67856), Meimian Hua (11162428), Tao Wang (12008), Wenhui Zhang (425538), Gang Huang (136671), Ziwei Wang (3344528), Guosheng Yang (1359387), Xiaojun Lu (195909), Qing Chen (131379)   +11 more
core   +1 more source

Aggressive co-existence: Collecting duct and clear cell carcinoma in the same kidney

Urology Research and Practice, 2019
As in every organ, synchronous multiple cancers are rarely encountered in kidneys. In the literature, mostly co-existence of renal cell carcinoma and transitional cell carcinoma was reported.
Abdullah Hızır Yavuzsan, Mithat Ekşi, Fırat Baytekin, Volkan Tuğcu   +3 more
doaj   +1 more source

Renal Collecting Duct Carcinoma in a Dog [PDF]

Veterinary Pathology, 2008
An 8-year-old, male, mongrel dog developed severe cough and anorexia and died within 3 months. Autopsy revealed an invasive grayish-white mass in the right kidney and multiple nodules in the lungs, thoracic wall, and spleen. Histologically, the renal mass and the other nodules were mainly composed of papillotubular structures lined by oval-to ...
N, Kobayashi, K, Suzuki, H, Shibuya, T, Sato, I, Aoki, Y, Nagashima   +5 more
openaire   +2 more sources

Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication. [PDF]

Cancers (Basel), 2020
Collecting duct carcinoma (CDC) is rare and aggressive histology of kidney cancers. Although different therapeutic approaches have been tested, the 2-year survival remains very poor.
Costantini M, Amoreo CA, Torregrossa L, Alì G, Munari E, Jeronimo C, Henrique R, Petronilho S, Capitanio U, Lucianò R, Suardi N, Landi MT, Anceschi U, Brassetti A, Fazio VM, Gallucci M, Simone G, Sentinelli S, Poeta ML.   +18 more
europepmc   +3 more sources

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC

Hepatology, EarlyView., 2022
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu, Bingqing Xu, Xiaodong Wang, Wen‐Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, Wenhua You, Hua Sun, Xiaoxin Mu, Dongju Feng, Yun Chen   +11 more
wiley   +1 more source